TCON - Upcoming Phase 3 Data on 03/31/2024
TRACON Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer and utilizing its cost efficient, contract research organization (CRO) independent product development platform to partner with ex-U.S. companies to develop and commercialize innovative products in the United States. The company's drug candidate includes Envafolimab, TRC102, TRC253, and Bispecific Antibodies.
This is not a financial advice!
Upcoming Phase 3 Data on 03/31/2024
We already have seen a big push - be carful on this play
Shs Float 40.26M
Rel. Vol. on 03/22/24 at 3.68
We need to stay in a bullish overal sentiment of the market. If we see a corretion, this play might doesn't work.
I see a small PB to 0.4 area - where is a good buying zone.
Keep an eye on 0.57 level, needs to get broken for a further upmove. You can take partial profits at this level if u want to lock in gains.
SL under 0.35
TP approx. 1.0
Most info on the chart.
Trade carefully!
This is not a financial advice!
Upcoming Phase 3 Data on 03/31/2024
We already have seen a big push - be carful on this play
Shs Float 40.26M
Rel. Vol. on 03/22/24 at 3.68
We need to stay in a bullish overal sentiment of the market. If we see a corretion, this play might doesn't work.
I see a small PB to 0.4 area - where is a good buying zone.
Keep an eye on 0.57 level, needs to get broken for a further upmove. You can take partial profits at this level if u want to lock in gains.
SL under 0.35
TP approx. 1.0
Most info on the chart.
Trade carefully!
Trade closed: stop reached